Index of reports
> Cases with Sinoatrial Block (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Noxafil (Posaconazole) where reactions include sinoatrial block. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Noxafil side effects in 34 year old female
Reported by a individual with unspecified qualification from Denmark on 2011-12-23
Patient: 34 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Nodal Arrhythmia, Bradyarrhythmia, Drug Interaction, Arrhythmia, Atrioventricular Block Second Degree, Sinus Bradycardia, Bradycardia, Sinus Tachycardia, Sinoatrial Block
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Allopurinol
Dosage: 100 mg, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pantoprazole Sodium
Dosage: 40 mg,
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Noxafil
Dosage: 40 mg, oral suspension 4 x
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-20
End date: 2008-01-25
Dexamethasone Sodium Phosphate
Indication: Product Used FOR Unknown Indication
Ondansetron
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Acyclovir
Dosage: 200 mg, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Product Used FOR Unknown Indication
Vogalene (Metopimazine)(metopimazine)
Indication: Product Used FOR Unknown Indication
Potassium Chloride
Dosage: 750 mg, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Etoposide
Indication: Product Used FOR Unknown Indication
Possible Noxafil side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-12-15
Patient: female
Reactions: Nodal Arrhythmia, Bradyarrhythmia, Drug Interaction, Arrhythmia, Sinus Bradycardia, Atrioventricular Block Second Degree, Bradycardia, Sinus Tachycardia, Sinoatrial Block
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Noxafil
Dosage: 200mg four times per day
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-20
End date: 2008-01-25
Cytarabine
Indication: Product Used FOR Unknown Indication
Dexamethasone
Indication: Product Used FOR Unknown Indication
Ondansetron
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Vogalene
Indication: Product Used FOR Unknown Indication
Acyclovir
Indication: Product Used FOR Unknown Indication
Etoposide
Indication: Product Used FOR Unknown Indication
Pantoprazole Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Potassium Chloride
Dosage: 750mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Allopurinol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Noxafil side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-12-12
Patient: 34 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Nodal Arrhythmia, Hepatosplenic Candidiasis, Drug Interaction, Sinoatrial Block, Sinus Tachycardia, Atrioventricular Block Second Degree
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vogalene
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Product Used FOR Unknown Indication
Ondansetron
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Potassium Chloride
Dosage: 750 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Allopurinol
Dosage: 100 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pantoprazole Sodium
Dosage: 40 mg milligram(s)
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Noxafil
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-20
End date: 2008-01-25
Etoposide
Indication: Product Used FOR Unknown Indication
Acyclovir
Dosage: 200 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Noxafil side effects in 34 year old female
Reported by a physician from Denmark on 2011-12-08
Patient: 34 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Sinoatrial Block
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Etoposide
Indication: Acute Leukaemia in Remission
Noxafil
Dosage: mixture
Indication: Candidiasis
Start date: 2007-10-19
Ondansetron
Indication: Prophylaxis of Nausea and Vomiting
Cytarabine
Indication: Acute Leukaemia in Remission
Other drugs received by patient: Pantoprazole Sodium; Potassium Chloride; Acyclovir; Allopurinol; Vogalene; Dexamethasone
Possible Noxafil side effects in 34 year old female
Reported by a physician from Denmark on 2011-10-11
Patient: 34 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Arrhythmia Supraventricular, Nodal Arrhythmia, Drug Interaction, Arrhythmia, Atrioventricular Block Second Degree, Bradycardia, Sinoatrial Block, Sinus Tachycardia, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ondansetron Hydrochloride
End date: 2008-01-22
Acyclovir
Dosage: 200 mg
Cytarabine
Noxafil
Dosage: 200 mg; qid; po
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-19
End date: 2008-01-25
Potassium Chloride
Dosage: 750 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pantoprazole
Dosage: 40 mg
Allopurinol
Dosage: 100 mg; po
Administration route: Oral
Etoposide
Vogalene
Possible Noxafil side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-10-06
Patient: female
Reactions: Drug Interaction, Sinoatrial Block, Atrioventricular Block Second Degree
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Allopurinol
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pantoprazole Sodium
Dosage: (df)
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Vogalene (Vogalene - Metopimazine) (Not Specified)
Dosage: (df)
Indication: Product Used FOR Unknown Indication
Etoposide
Dosage: (df)
Indication: Product Used FOR Unknown Indication
Acyclovir
Dosage: df
Noxafil
Dosage: (800 mg oral)
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-19
End date: 2008-01-25
Zofran
Dosage: (df)
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Kaleorid (Kaleorid - Potassium Chloride) 750 MG (Not Specified)
Dosage: (750 mg)
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Cytarabine
Possible Noxafil side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-10-03
Patient: 34 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Drug Interaction, Sinus Tachycardia, Sinoatrial Block, Sinus Bradycardia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Noxafil
Dosage: 400 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-19
End date: 2008-01-25
Etoposide
Indication: Product Used FOR Unknown Indication
Acyclovir
Dosage: 200 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ondansetron
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Vogalene
Indication: Product Used FOR Unknown Indication
Allopurinol
Dosage: 100 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Product Used FOR Unknown Indication
Pantoloc / 01263204 / )
Dosage: 40 mg milligram(s)
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Potassium Chloride
Dosage: 750 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
|